Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has provided an update.
NeuroScientific Biopharmaceuticals Limited reported a 5% increase in revenues for the half-year ending December 2024, while significantly reducing its loss by 70% compared to the previous period. Despite not declaring a dividend, the company improved its net tangible assets per share from 2.44 cents to 3.23 cents, indicating a stronger financial position.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Limited operates in the biopharmaceutical industry, focusing on the development of therapeutic products targeting neurodegenerative conditions. The company is committed to advancing treatments that address significant unmet medical needs in neurological health.
YTD Price Performance: 26.67%
Average Trading Volume: 173,843
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.49M
Learn more about NSB stock on TipRanks’ Stock Analysis page.